Treatment patterns in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis
Yazar
Hitier, S.
Ozguroglu, M.
Karavasilis, V.
Ecstein-Fraisse, E. B.
Bensfia, S.
Akaza, H.
Procopio, G.
Pripatnanont, C.
Facchini, G.
Fava, S.
Wheatley, D.
Leung, K. C.
Butt, M.
Silva, A.
Castillo, L.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]